 Drugs in Dev.
 Drugs in Dev.								 Ophthalmology
Ophthalmology
											 Phase I
Phase I
											
																			 Israel
Israel								
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : ST266
Therapeutic Area : Ophthalmology
Study Phase : Phase I
Sponsor : Noveome Biotherapeutics
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : ST266 is a cell-free biologic containing hundreds of proteins and other factors involved in cellular healing, neuroprotection, and modulation of inflammation. Agreement furthers study of intranasal delivery of ST266 for ophthalmology and brain-related co...
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Undisclosed
June 01, 2021
Lead Product(s) : ST266
Therapeutic Area : Ophthalmology
Highest Development Status : Phase I
Sponsor : Noveome Biotherapeutics
Deal Size : Undisclosed
Deal Type : Licensing Agreement


 
															 Reset All
Reset All